- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PF-04457845, FAAH inhibitor
Total 453 results
-
National Cancer Institute (NCI)Active, not recruitingMale Breast Carcinoma | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States, Puerto Rico
-
PfizerArvinas Estrogen Receptor, Inc.Completed
-
PfizerCompleted
-
PfizerCompleted
-
PfizerCompleted
-
PfizerCompletedHealthy ParticipantsUnited States
-
PfizerTerminatedAcute Myeloid LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Mantle Cell Lymphoma | Transformed Follicular Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterTerminated
-
PfizerArvinas Estrogen Receptor, Inc.RecruitingBreast CancerUnited States, China, Spain, Hungary, Japan, Australia, Brazil, Italy, Slovakia, Switzerland
-
Merck Sharp & Dohme LLCPfizerCompleted
-
PfizerCompletedHealthy ParticipantUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI)CompletedPancreatic NeoplasmsUnited States
-
PfizerCompleted
-
PfizerCompletedHeathy ParticipantsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma and other conditionsUnited States
-
PfizerWithdrawn
-
PfizerTerminatedNeoplasmsUnited States, Australia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Recurrent Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Positive | Progesterone Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7 | Postmenopausal | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 and other conditionsUnited States
-
PfizerCompletedDiabetes Mellitus Type 2United States
-
University of FloridaPfizerTerminatedNon-Small Cell Lung CancerUnited States
-
PfizerTerminatedPost-surgical Dental PainUnited States
-
Cancer Research UKCompletedBreast Cancer | Ovarian Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited Kingdom
-
PfizerTerminatedIschemic StrokeUnited States, Taiwan, Korea, Republic of, India, Germany, Canada, France, Bulgaria, Czech Republic, Hungary
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingRecurrent Colon Carcinoma | Recurrent Rectal Carcinoma | Rectal Adenocarcinoma | Colon Adenocarcinoma | ERBB2 Gene Amplification | Stage III Colon Cancer AJCC v7 | Stage III Rectal Cancer AJCC v7 | Stage IIIA Colon Cancer AJCC v7 | Stage IIIA Rectal Cancer AJCC v7 | Stage IIIB Colon Cancer AJCC v7 | Stage... and other conditionsUnited States, Puerto Rico
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Lung Non-Squamous Non-Small Cell CarcinomaUnited States
-
Dana-Farber Cancer InstitutePfizerCompleted
-
PfizerCompletedHealthy ParticipantBelgium
-
PfizerCompletedPostoperative Dental PainUnited States
-
PfizerEli Lilly and Company; Merck Sharp & Dohme LLC; Merck KGaA, Darmstadt, GermanyRecruitingMetastatic Colorectal CancerUnited States, Denmark, Spain, Australia, France, Italy, Belgium, Slovakia, Canada, Czechia, Germany, Netherlands, Norway, Poland, Sweden, United Kingdom
-
PfizerCompletedAcute Myeloid LeukemiaJapan
-
PfizerCompletedAcute Myeloid LeukemiaUnited States, Spain, Germany, Italy, Poland, Canada
-
Mylan Pharmaceuticals IncCompleted
-
Mylan Pharmaceuticals IncCompleted
-
PfizerCompleted
-
University of FloridaCompleted
-
PfizerCompletedLeukemia, Myeloid, AcuteUnited States, Spain, Canada, Israel, Korea, Republic of, Taiwan, France, Australia, Germany, Mexico, Japan, Sweden, China, Austria, Belgium, Czechia, Hungary, Italy, Poland, Romania, Russian Federation, United Kingdom
-
PfizerCompletedHealthyUnited States
-
PfizerCompletedGlucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes MellitusUnited States
-
PfizerCompletedGlucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes MellitusUnited States
-
Boryung Pharmaceutical Co., LtdCompletedDrug-Drug InteractionKorea, Republic of
-
Mylan Pharmaceuticals IncCompleted
-
PfizerCompleted
-
Mylan Pharmaceuticals IncCompletedHealthyUnited States
-
Jonsson Comprehensive Cancer CenterEli Lilly and Company; Genentech, Inc.RecruitingMetastatic Lung Non-Small Cell Carcinoma | Refractory Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v8 | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8United States
-
Nanjing Medical UniversityCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Mantle Cell Lymphoma | CCND1 Positive | CCND2 Positive | CCND3 Positive | CD20 Positive | Refractory Mantle Cell LymphomaUnited States
-
PfizerTerminatedAdvanced Non-squamous NSCLCChina